Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:actsOn |
tyrosine hydroxylase inhibitor
|
| gptkbp:administeredBy |
oral route
|
| gptkbp:ATCCode |
L01XX19
|
| gptkbp:CASNumber |
536-38-9
|
| gptkbp:contraindication |
pregnancy
|
| gptkbp:hasMolecularFormula |
C10H13NO3
|
| gptkbp:hasUNII |
8X1WZ9D43J
|
| https://www.w3.org/2000/01/rdf-schema#label |
alpha-methyl-p-tyrosine
|
| gptkbp:is_used_to_treat |
gptkb:pheochromocytoma
|
| gptkbp:IUPACName |
(S)-2-amino-3-(4-hydroxyphenyl)-2-methylpropanoic acid
|
| gptkbp:marketedAs |
Demser
|
| gptkbp:molecularWeight |
195.22 g/mol
|
| gptkbp:notableDerivative |
gptkb:tyrosine
|
| gptkbp:PubChem_CID |
4067
|
| gptkbp:regulates |
gptkb:FDA
|
| gptkbp:sideEffect |
gptkb:depression
anxiety sedation |
| gptkbp:synonym |
metyrosine
|
| gptkbp:bfsParent |
gptkb:tyrosine_hydroxylase
|
| gptkbp:bfsLayer |
7
|